Fill Finish Manufacturing Market Segmentation by Design (Single-Chamber, Dual-Chamber, and Customized Prefilled Syringes); by Usability Type (Disposable, and Reusable); by Packaging Type (Glass, and Plastic Prefilled Syringes); by Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis, Vaccine, Biopharmacy, Antithrombotic, and Others); by Combination Products (Single Entity, Co-Packaged, and Cross-Labeled Combination Products); and by End-User (Contract Manufacturing Organizations, Biopharmaceutical Companies, and Pharmaceutical Companies)-Global Demand Analysis & Opportunity Outlook 2021-2031

  • Product Code:
    RP-ID-10352361
  • Published Date:
    16 Feb 2022
  • Region:
    Global
  • Pages:
    209
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-54

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

The Research Report is Updated with 2020 Base Year, 2021 Estimated year and Forecast till 2030 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2020 as base year, 2021 as estimated year and forecast to 2030. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Global Fill Finish Manufacturing Market Highlights Over 2021 - 2031

The global fill finish manufacturing market is estimated to garner a revenue of USD 15828.8 Million by the end of 2031 by growing at a CAGR of 10.70% over the forecast period, i.e., 2022 – 2031. Moreover, in the year 2021, the market generated a revenue of USD 5762.0 Million. The growth of the market can primarily be attributed to the rising incidences of different types of chronic diseases globally, which is driving the need for different types of advanced medicines to treat these diseases. For instance, the prevalence of the chronic disease, diabetes, in the year 2019, was known to be the ninth leading cause of death, according to the statistics by the World Health Organization (WHO). Moreover, in the same year, around 1.5 Million people were known to die due to the chronic disease. Further, the rise in adoption of self-injecting parental drug devices is also expected to drive the market growth in the coming years. Prefilled syringes and injection devices are gaining strong acceptance as delivery systems for injectable drugs. These are mainly used to treat chronic conditions where patients are required to self-administer their medications. With the rise in adoption of parenteral drugs, especially biologics, there is a growing need among pharmaceutical drug manufacturers to design more sophisticated container closure and drug delivery systems, which is anticipated to drive the market growth.

 

Fill Finish Manufacturing Market

 

CLICK TO DOWNLOAD SAMPLE REPORT

 

On the other hand, the increasing advancements in the field of drug delivery systems, backed by the rising healthcare expenditure globally, and the surge in investments for research and developments in the field of advanced medications for different types of diseases, are also expected to drive the market growth. Besides this, it is also expected that with the development of COVID-19 vaccines to treat SARS-CoV-2 infections, these vaccines may migrate to a single-dose prefilled syringe to reduce waste and avoid the expiry of unused vaccine doses. Such a factor is also anticipated to drive the growth of the market in the coming years.

Global Fill Finish Manufacturing Market Regional Synopsis

Regionally, the global fill finish manufacturing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Europe is anticipated to garner the largest revenue of USD 6004.7 Million by the end of 2031, by growing from a revenue of USD 2425.8 Million in the year 2021. The growth of the market in the region can primarily be attributed to the presence of several pharmaceutical drug manufacturers and their focus on developing advanced drug delivery systems. The pharmaceutical industry in Europe is also one of the largest industries in the world, in terms of value of production and exports. According to the statistics by the European Federation of Pharmaceutical Industries and Associations (efpia), the value of production of the pharmaceutical industry in Europe registered USD 118642.47 Million in the year 2000, and was estimated to reach a value of USD 380401 Million by the end of 2020. The market in the region is further segmented by country into Germany, United Kingdom, France, Italy, Spain, Russia, Netherland, and the Rest of Europe. Out of these, the market in Germany is anticipated to garner the largest revenue of USD 1208.5 Million by the end of 2031, up from a revenue of USD 443.9 Million in the year 2021.

Growth Drivers and Challenges Impacting the Growth of the Global Fill Finish Manufacturing Market

Growth Drivers

  • Growing Adoption of Self-Injecting Parental Devices

  • Increasing Demand for Pre-Filled Syringes for COVID-19 Vaccines

Challenges

  • Risks Associated with the Packaging of Pre-Filled Syringes

  • Availability of Lose-Cost Alternative

Global Fill Finish Manufacturing Market Segmentation Synopsis

The global fill finish manufacturing market is segmented by design into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. Out of these, the single-chamber prefilled syringes segment is anticipated to generate the largest revenue of USD 11233.1 Million by the end of 2031, up from a revenue of USD 4142.3 Million in the year 2021. By usability type, the market is segmented into disposable and reusable, out of which the disposable segment is anticipated to garner the largest revenue by the end of 2031 and also grow with the highest CAGR of 10.82% during the forecast period. By packaging type, the market is segmented into glass prefilled syringes, and plastic prefilled syringes, out of which, the glass prefilled syringes segment is anticipated to garner the largest revenue by the end of 2031. By application, the market is segmented into diabetes, anaphylaxis, rheumatoid arthritis, vaccine, biopharmacy, antithrombotic, and others. Out of these, the vaccine segment is anticipated to garner the largest revenue of USD 3505.9 Million by the end of 2031, up from a revenue of USD 1224.9 Million in the year 2021. By combination products, the market is segmented into single entity combination products, co-packaged combination products, and cross-labeled combination products. Out of these, the single entity combination products segment is anticipated to garner the largest revenue of USD 7402.5 Million by the end of 2031, up from a revenue of USD 2682.6 Million in the year 2021. By end-user the market is segmented into contract manufacturing organizations, biopharmaceutical companies, and pharmaceutical companies. Out of these, biopharmaceutical companies segment is anticipated to garner the largest revenue of USD 6906.3 Million by the end of 2031, up from a revenue of USD 2469.7 Million in the year 2021.

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global fill finish manufacturing market that are included in our report are Becton, Dickinson and Company, B. Braun Melsungen AG, Catalent, Inc., AbbVie Inc., Baxter International Inc., Gerresheimer AG, Medefil, Inc., SCHOTT AG, West Pharmaceutical Services, Inc., MedXL Inc., NIPRO Corporation, Terumo Corporation, Taisei Kako Ltd., Otsuka Pharmaceutical Factory, Inc., and others.

Latest Developments in the Global Fill Finish Manufacturing Market:

  • December 2nd, 2020: BD (Becton, Dickinson and Company) announced that over a period of four years, the company would invest around USD 1.2 Billion across its six global manufacturing locations to expand and upgrade the manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS). The investment would also include adding a new manufacturing facility in Europe.

  • June 25th, 2020: Catalent, Inc. announced that it has collaborated with Moderna, Inc. for large-scale commercial fill-finish manufacturing of the mRNA-based COVID-19 vaccine candidate (mRNA-1273) of Moderna at the biologics facility of Catalent in Bloomington, Indiana.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.

  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.

  • The report includes detailed company profiles of the major players dominating the market.

  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.

  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

FREQUENTLY ASKED QUESTIONS

1.      Market Definition

1.1.  Definition

1.2.Market Segmentation

2.     Assumptions

3.     Research Methodology

3.1. Research Process

3.2.                     Primary Research

3.3.                     Secondary Research

4.    Executive Summary – Fill Finish Manufacturing Market

5.     Market Dynamics

5.1. Market Drivers

5.2.                     Market Trends

6.    Key Market Opportunities

7.     Major Roadblocks for the Market Growth

8.    Regulatory & Standards Landscape

9.    Industry Risk Analysis

10.            Pricing Analysis

11.  Value Chain Analysis

12. Design Analysis of Pre-Filled Syringe

13. Product Feature Analysis

14.Industry Growth Outlook

15. Competitive Positioning

16.Competitive Landscape

16.1.                  Market Share Analysis, 2021

16.2.                 Competitive Benchmarking

16.3.                 Company Profiles

16.3.1.                      Becton, Dickinson and Company

16.3.2.                     B. Braun Melsungen AG

16.3.3.                     Catalent, Inc.

16.3.4.                     AbbVie Inc.

16.3.5.                     Baxter International Inc.

16.3.6.                     Gerresheimer AG

16.3.7.                      Medefil, Inc.

16.3.8.                     SCHOTT AG

16.3.9.                     West Pharmaceutical Services, Inc.

16.3.10.                MedXL Inc.

16.3.11.                  NIPRO Corporation

16.3.12.                 Terumo Corporation

16.3.13.                 Taisei Kako Ltd.

16.3.14.                 Otsuka Pharmaceutical Factory, Inc.

17. Global Fill Finish Manufacturing Market 2021-2031

17.1.                  Market Overview

17.2.                 By Value (USD Million)

17.3.                 Segmentation Analysis

17.3.1.                       By Design

17.3.1.1.    Single-Chamber Prefilled Syringe

17.3.1.2.   Dual-Chamber Prefilled Syringe

17.3.1.3.   Customized Prefilled Syringe

17.3.2.                      By Usability Type

17.3.2.1.   Disposable

17.3.2.2.  Reusable

17.3.3.                      By Packaging Type

17.3.3.1.   Glass Prefilled Syringes

17.3.3.2.  Plastic Prefilled Syringes

17.3.4.                      By Applications

17.3.4.1.   Diabetes

17.3.4.2.  Anaphylaxis

17.3.4.3.  Rheumatoid Arthritis

17.3.4.4.  Vaccine

17.3.4.5.  Biopharmacy

17.3.4.6.  Antithrombotic

17.3.4.7.  Others

17.3.5.                      By Combination Products

17.3.5.1.   Single Entity Combination Products

17.3.5.2.  Co-Packaged Combination Products

17.3.5.3.  Cross-Labeled Combination Products

17.3.6.                      By End-User

17.3.6.1.   Contract Research Organizations (CROs)

17.3.6.2.  Biopharmaceutical Companies

17.3.6.3.  Pharmaceutical Companies

17.3.7.                      By Region

17.3.7.1.    North America

17.3.7.2.  Europe

17.3.7.3.  Asia Pacific

17.3.7.4.  Latin America

17.3.7.5.   Middle East & Africa

18.            North America Fill Finish Manufacturing Market 2021-2031

18.1.                  Market Overview

18.2.                By Value (USD Million)

18.3.                Segmentation Analysis

18.3.1.                      By Design

18.3.1.1.   Single-Chamber Prefilled Syringe

18.3.1.2.  Dual-Chamber Prefilled Syringe

18.3.1.3.  Customized Prefilled Syringe

18.3.2.                     By Usability Type

18.3.2.1.  Disposable

18.3.2.2. Reusable

18.3.3.                     By Packaging Type

18.3.3.1.  Glass Prefilled Syringes

18.3.3.2. Plastic Prefilled Syringes

18.3.4.                     By Applications

18.3.4.1.  Diabetes

18.3.4.2. Anaphylaxis

18.3.4.3. Rheumatoid Arthritis

18.3.4.4. Vaccine

18.3.4.5. Biopharmacy

18.3.4.6. Antithrombotic

18.3.4.7. Others

18.3.5.                     By Combination Products

18.3.5.1.  Single Entity Combination Products

18.3.5.2. Co-Packaged Combination Products

18.3.5.3. Cross-Labeled Combination Products

18.3.6.                     By End-User

18.3.6.1.  Contract Research Organizations (CROs)

18.3.6.2. Biopharmaceutical Companies

18.3.6.3. Pharmaceutical Companies

18.3.7.                     By Country

18.3.7.1.   United States

18.3.7.2. Canada

19.Europe Fill Finish Manufacturing Market 2021-2031

19.1.                  Market Overview

19.2.                 By Value (USD Million)

19.3.                 Segmentation Analysis

19.3.1.                      By Design

19.3.2.                     By Usability Type

19.3.3.                     By Packaging Type

19.3.4.                     By Applications

19.3.5.                     By Combination Products

19.3.6.                     By End-User

19.3.7.                      By Country

19.3.7.1.   Germany

19.3.7.2.  United Kingdom

19.3.7.3.  France

19.3.7.4.  Italy

19.3.7.5.  Spain

19.3.7.6.  Russia

19.3.7.7.  Netherland

19.3.7.8. Rest of Europe

20.           Asia Pacific Fill Finish Manufacturing Market 2021-2031

20.1.                Market Overview

20.2.               By Value (USD Million)

20.3.               Segmentation Analysis

20.3.1.                     By Design

20.3.2.                   By Usability Type

20.3.3.                   By Packaging Type

20.3.4.                   By Applications

20.3.5.                    By Combination Products

20.3.6.                   By End-User

20.3.7.                    By Country

20.3.7.1. China

20.3.7.2.                        India

20.3.7.3.                        Japan

20.3.7.4.                        South Korea

20.3.7.5.Australia

20.3.7.6.                        Singapore

20.3.7.7. Rest of APAC

21. Latin America Fill Finish Manufacturing Market 2021-2031

21.1.                  Market Overview

21.2.                 By Value (USD Million)

21.3.                 Segmentation Analysis

21.3.1.                      By Design

21.3.2.                     By Usability Type

21.3.3.                     By Packaging Type

21.3.4.                     By Applications

21.3.5.                     By Combination Products

21.3.6.                     By End-User

21.3.7.                      By Country

21.3.7.1.   Brazil

21.3.7.2.  Argentina

21.3.7.3.  Mexico

21.3.7.4.  Rest of LATAM

22.           Middle East & Africa Fill Finish Manufacturing Market 2021-2031

22.1.                 Market Overview

22.2.                By Value (USD Million)

22.3.                Segmentation Analysis

22.3.1.                     By Design

22.3.2.                    By Usability Type

22.3.3.                    By Packaging Type

22.3.4.                    By Applications

22.3.5.                    By Combination Products

22.3.6.                    By End-User

22.3.7.                    By Country

22.3.7.1.  GCC

22.3.7.2. Israel

22.3.7.3. South Africa

22.3.7.4. Rest of MEA

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
  1. Becton, Dickinson and Company
  2. B. Braun Melsungen AG
  3. Catalent, Inc.
  4. AbbVie Inc.
  5. axter International Inc.
  6. Gerresheimer AG
  7. Medefil, Inc.
  8. SCHOTT AG
  9. West Pharmaceutical Services, Inc.
  10. MedXL Inc.
  11. NIPRO Corporation
  12. Terumo Corporation
  13. Taisei Kako Ltd.
  14. Otsuka Pharmaceutical Factory, Inc.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports